Desktop Site |
21 Nov 24 | 15:59 | Close
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 77,155.79 -422.59 -0.54 %
Corporate Announcement
  • Security Code543594
    CompanyDipna Pharmachem Ltd
    Exchange Received Time11/10/2024 19:18:12
    Exchange Disseminated Time11/10/2024 19:18:14
    Time Taken00:00:02
     
     
     Board Meeting Outcome for Submission Of Outcome Of Board Meeting And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | 10/11/24 19:18 
     Pursuant to the second proviso to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors in their meeting held today i.e. 11th October, 2024 at the Registered Office of the Company situated at A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad - 380 055 which commenced at 5:30 P. M. and concluded at 7:00 P.M. inter-alia has, considered and approved appointment of Mr. Nirav Soni (DIN: 08317653) as Additional Non-Executive and Non-Independent Director of the Company w.e.f. 11th October, 2024. The details required under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 09/09/2015 and SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated 11/07/2023 are given in Annexure A. Kindly take the same on your record and oblige us. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(20H) 21 Nov 24|17:31 (IST)